Myofascial Release and Muscle Activity
Primary Purpose
Self Myofascial Release, Muscle Tone Abnormalities
Status
Unknown status
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
SelfMyofascial Release
Sponsored by
About this trial
This is an interventional basic science trial for Self Myofascial Release
Eligibility Criteria
Inclusion Criteria:
- signing informed consent to participate in the study
- age in the range of 18-40 years
Exclusion Criteria:
- people who had orthopedic injuries to the lower limbs and the lumbar-pelvic-iliac complex in the last year
- people who reported pain in the lower limbs and the lumbar-pelvic-iliac complex on the day of the examination
- people who underwent myofascial therapy in the last 6 weeks
- people with non-specific neuromuscular disorders
Sites / Locations
- Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, PolandRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Players of amateur football leagues
Control group
Arm Description
The players of amateur football leagues who will receive SelfMyofascial Release intervention
The players of amateur football leagues who will receive no intervention
Outcomes
Primary Outcome Measures
1. Surface electromyography (sEMG) examination before SMR
The sEMG examination of the biceps and gluteus muscles will be performed using the MyoTrace 400 recorder by Noraxon USA Inc. with a sampling frequency of 1000 Hz, using the bipolar method, in accordance with SENIAM standards.The bioelectrical activity of the muscles will be tested during the squat.
Surface electromyography (sEMG) examination immediately after SMR
The change in bioelectrical activity of the biceps and gluteus muscles will be performed. The bioelectrical activity of the muscles will be tested during the squat.
Surface electromyography (sEMG) examination 5 minutes after SMR
The change in bioelectrical activity of the biceps and gluteus muscles will be performed. The bioelectrical activity of the muscles will be tested during the squat.
Secondary Outcome Measures
Full Information
NCT ID
NCT04808024
First Posted
March 16, 2021
Last Updated
March 17, 2021
Sponsor
Medical University of Silesia
1. Study Identification
Unique Protocol Identification Number
NCT04808024
Brief Title
Myofascial Release and Muscle Activity
Official Title
Self Myofascial Release (SMR) and Bioelectrical Activity of Muscles
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
April 21, 2021 (Anticipated)
Study Completion Date
May 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Silesia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to assess the impact of SMR intervention in the hamstring muscles on the activity of the biceps and gluteus muscles.
Detailed Description
The study will cover 40 men, players of amateur football leagues, aged 18 - 40. The test will include the measurement of sEMG of the biceps and gluteal muscles during the exercise, followed by myofascial self-release (SMR). Muscle sEMG was re-measured immediately after roller therapy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Self Myofascial Release, Muscle Tone Abnormalities
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Players of amateur football leagues
Arm Type
Experimental
Arm Description
The players of amateur football leagues who will receive SelfMyofascial Release intervention
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The players of amateur football leagues who will receive no intervention
Intervention Type
Procedure
Intervention Name(s)
SelfMyofascial Release
Intervention Description
Myofascial auto-release consisted of rolling the roller on a group of knee flexors for 3.5 minutes between the sciatic tumor and the knee joint in both directions, omitting the popliteal fossa. Before and after the intervention, sEMG of the biceps and gluteal muscles will be performed.
Primary Outcome Measure Information:
Title
1. Surface electromyography (sEMG) examination before SMR
Description
The sEMG examination of the biceps and gluteus muscles will be performed using the MyoTrace 400 recorder by Noraxon USA Inc. with a sampling frequency of 1000 Hz, using the bipolar method, in accordance with SENIAM standards.The bioelectrical activity of the muscles will be tested during the squat.
Time Frame
Before the SMR intervention
Title
Surface electromyography (sEMG) examination immediately after SMR
Description
The change in bioelectrical activity of the biceps and gluteus muscles will be performed. The bioelectrical activity of the muscles will be tested during the squat.
Time Frame
Immediately after the SMR intervention
Title
Surface electromyography (sEMG) examination 5 minutes after SMR
Description
The change in bioelectrical activity of the biceps and gluteus muscles will be performed. The bioelectrical activity of the muscles will be tested during the squat.
Time Frame
5 minutes after the SMR intervention
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
signing informed consent to participate in the study
age in the range of 18-40 years
Exclusion Criteria:
people who had orthopedic injuries to the lower limbs and the lumbar-pelvic-iliac complex in the last year
people who reported pain in the lower limbs and the lumbar-pelvic-iliac complex on the day of the examination
people who underwent myofascial therapy in the last 6 weeks
people with non-specific neuromuscular disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Piotr Michalik
Phone
694979743
Email
piotrmichalikk@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Tomasz Król
Email
tkrol@sum.edu.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Magdalena Dąbrowska-Galas
Organizational Affiliation
Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia in Katowice, Katowice, Poland
Official's Role
Study Director
Facility Information:
Facility Name
Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland
City
Katowice
State/Province
Śląskie
ZIP/Postal Code
40-752
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Magdalena Dąbrowska-Galas, Phd
Phone
515321323
Ext
048
Email
magdalena.j.dabrowska@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
The datasets used and / or analyzed in the present study will be available from the respective author upon reasonable request.
Learn more about this trial
Myofascial Release and Muscle Activity
We'll reach out to this number within 24 hrs